drugset / Trial / NCT01755845

Trial of Postoperative Chemoradiotherapy With or Without Consolidation Chemotherapy for Cervical Cancer Patients

NCT01755845 ↗

Phase 3 Unknown 300 enrolled xie congying
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of consolidation chemotherapy with paclitaxel plus cisplatin (2 cycles per 3 weeks) following radical hysterectomy and adjuvant chemoradiation (2 cycles per 4 weeks) for high risk early stage cervical cancer.

Timeline

Start
2011-01
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 25 mg/m2 Intravenous
Subject Paclitaxel Small molecule 135 mg/m2 Intravenous

Indications